Literature DB >> 23392573

Role of IL-18 in second-hand smoke-induced emphysema.

Adelheid Kratzer1, Jonas Salys, Claudia Nold-Petry, Carlyne Cool, Martin Zamora, Russ Bowler, Andreas Rembert Koczulla, Sabina Janciauskiene, Michael G Edwards, Charles A Dinarello, Laimute Taraseviciene-Stewart.   

Abstract

Chronic second-hand smoke (SHS) exposure comprises the main risk factor for nonsmokers to develop chronic obstructive pulmonary disease (COPD). However, the mechanisms behind the chronic inflammation and lung destruction remain incompletely understood. In this study, we show that chronic exposure of Sprague-Dawley rats to SHS results in a significant increase of proinflammatory cytokine IL-18 and chemokine (C-C motif) ligand 5 in the bronchoalveolar lavage fluid (BALF) and a significant decrease of vascular endothelial growth factor (VEGF) in the lung tissue. SHS exposure resulted in progressive alveolar airspace enlargement, cell death, pulmonary vessel loss, vessel muscularization, collagen deposition, and right ventricular hypertrophy. Alveolar macrophages displayed a foamy phenotype and a decreased expression of the natural inhibitor of IL-18, namely, IL-18 binding protein (IL-18BP). Moreover, IL-18 down-regulated the expression of VEGF receptor-1 and VEGFR receptor-2, and induced apoptosis in pulmonary microvascular endothelial cells in vitro. We also observed a trend toward increased concentrations of IL-18 in the BALF of patients with COPD. Our findings suggest that IL-18-mediated endothelial cell death may contribute to vascular destruction and disappearance in SHS-induced COPD. Moreover, IL-18 and IL-18BP are potential new targets for therapeutics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392573      PMCID: PMC3727875          DOI: 10.1165/rcmb.2012-0173OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  59 in total

1.  Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18.

Authors:  S H Kim; M Eisenstein; L Reznikov; G Fantuzzi; D Novick; M Rubinstein; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure.

Authors:  Connie C W Hsia; Dallas M Hyde; Matthias Ochs; Ewald R Weibel
Journal:  Am J Respir Crit Care Med       Date:  2010-02-15       Impact factor: 21.405

3.  Indoor air quality at nine large-hub airports with and without designated smoking areas--United States, October-November 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-11-23       Impact factor: 17.586

4.  IL-18 induces emphysema and airway and vascular remodeling via IFN-γ, IL-17A, and IL-13.

Authors:  Min-Jong Kang; Je-Min Choi; Bo Hye Kim; Chang-Min Lee; Won-Kyung Cho; Gina Choe; Do-Hyun Kim; Chun Geun Lee; Jack A Elias
Journal:  Am J Respir Crit Care Med       Date:  2012-03-01       Impact factor: 21.405

5.  Alpha1-antitrypsin determines the pattern of emphysema and function in tobacco smoke-exposed mice: parallels with human disease.

Authors:  Yasutaka Takubo; Alexei Guerassimov; Heberto Ghezzo; Alexandra Triantafillopoulos; Jason H T Bates; John R Hoidal; Manuel G Cosio
Journal:  Am J Respir Crit Care Med       Date:  2002-12-15       Impact factor: 21.405

6.  Passive smoking in obstructive respiratory disease in an industrialized urban population.

Authors:  H H Dayal; S Khuder; R Sharrar; N Trieff
Journal:  Environ Res       Date:  1994-05       Impact factor: 6.498

7.  Interleukin-18 production and pulmonary function in COPD.

Authors:  H Imaoka; T Hoshino; S Takei; T Kinoshita; M Okamoto; T Kawayama; S Kato; H Iwasaki; K Watanabe; H Aizawa
Journal:  Eur Respir J       Date:  2007-11-07       Impact factor: 16.671

8.  Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease.

Authors:  Toshinori Yoshida; Rubin M Tuder
Journal:  Physiol Rev       Date:  2007-07       Impact factor: 37.312

Review 9.  The role of leptin in the respiratory system: an overview.

Authors:  Foteini Malli; Andriana I Papaioannou; Konstantinos I Gourgoulianis; Zoe Daniil
Journal:  Respir Res       Date:  2010-10-31

10.  COPD/emphysema: The vascular story.

Authors:  Norbert F Voelkel; Jose Gomez-Arroyo; Shiro Mizuno
Journal:  Pulm Circ       Date:  2011 Jul-Sep       Impact factor: 3.017

View more
  17 in total

1.  Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort.

Authors:  Nirupama Putcha; R Graham Barr; Meilan K Han; Prescott G Woodruff; Eugene R Bleecker; Richard E Kanner; Fernando J Martinez; Benjamin M Smith; Donald P Tashkin; Russell P Bowler; Mark D Eisner; Stephen I Rennard; Robert A Wise; Nadia N Hansel
Journal:  Thorax       Date:  2016-03-09       Impact factor: 9.139

2.  Obesity and extent of emphysema depicted at CT.

Authors:  S Gu; R Li; J K Leader; B Zheng; J Bon; D Gur; F Sciurba; C Jin; J Pu
Journal:  Clin Radiol       Date:  2015-02-19       Impact factor: 2.350

3.  A critical role for ABC transporters in persistent lung inflammation in the development of emphysema after smoke exposure.

Authors:  Jarrod Sonett; Monica Goldklang; Piotr Sklepkiewicz; Adam Gerber; Jordis Trischler; Tina Zelonina; Marit Westerterp; Vincent Lemaître; Yasunori Okada; Jeanine D'Armiento
Journal:  FASEB J       Date:  2018-06-15       Impact factor: 5.191

Review 4.  Alpha-1 Antitrypsin Investigations Using Animal Models of Emphysema.

Authors:  Kevin Ni; Karina A Serban; Chanan Batra; Irina Petrache
Journal:  Ann Am Thorac Soc       Date:  2016-08

Review 5.  Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.

Authors:  Lloyd Tanner; Andrew Bruce Single
Journal:  J Innate Immun       Date:  2019-09-17       Impact factor: 7.349

6.  Tobacco smoke induced COPD/emphysema in the animal model-are we all on the same page?

Authors:  Maike Leberl; Adelheid Kratzer; Laimute Taraseviciene-Stewart
Journal:  Front Physiol       Date:  2013-05-15       Impact factor: 4.566

Review 7.  Inflammation and immune response in COPD: where do we stand?

Authors:  Nikoletta Rovina; Antonia Koutsoukou; Nikolaos G Koulouris
Journal:  Mediators Inflamm       Date:  2013-07-15       Impact factor: 4.711

8.  Role of the inflammasome-caspase1/11-IL-1/18 axis in cigarette smoke driven airway inflammation: an insight into the pathogenesis of COPD.

Authors:  Suffwan Eltom; Maria G Belvisi; Christopher S Stevenson; Sarah A Maher; Eric Dubuis; Kate A Fitzgerald; Mark A Birrell
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

Review 9.  The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease.

Authors:  Adam Jerzy Białas; Przemysław Sitarek; Joanna Miłkowska-Dymanowska; Wojciech Jerzy Piotrowski; Paweł Górski
Journal:  Oxid Med Cell Longev       Date:  2016-12-26       Impact factor: 6.543

Review 10.  Cytokine inhibition in the treatment of COPD.

Authors:  Gaetano Caramori; Ian M Adcock; Antonino Di Stefano; Kian Fan Chung
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.